Literature DB >> 15967839

Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.

Vassilia Garipidou, Sofia Vakalopoulou, Konstantinos Tziomalos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967839     DOI: 10.1634/theoncologist.10-6-457

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  10 in total

1.  NESH protein expression switches to the adverse effect of imatinib mesylate.

Authors:  Satoru Matsuda; Yasukatu Ichigotani; Naoko Okumura; Hitomi Yoshida; Yuka Kajiya; Yasuko Kitagishi; Naoki Shirafuji
Journal:  Mol Oncol       Date:  2008-03-20       Impact factor: 6.603

Review 2.  Uncommon case of chronic myeloid leukemia with multiple myeloma.

Authors:  Masaru Ide; Nobuo Kuwahara; Eijo Matsuishi; Shinya Kimura; Hisashi Gondo
Journal:  Int J Hematol       Date:  2010-03-30       Impact factor: 2.490

3.  Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.

Authors:  Junko Yamaguchi; Takahiro Fujino; Reiko Isa; Daichi Nishiyama; Saeko Kuwahara-Ota; Yuka Kawaji; Taku Tsukamoto; Yoshiaki Chinen; Yuji Shimura; Tsutomu Kobayashi; Shigeo Horiike; Kei Kohno; Shigeo Nakamura; Junya Kuroda
Journal:  Haematologica       Date:  2019-04-11       Impact factor: 9.941

4.  Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.

Authors:  Hee Jin Kim; Moon Jin Kim; Min Jeong Lee; Jong-Hwa Ahn; Ho-Su Kim; In-Suk Kim; Jong Sil Lee; Gyeong-Won Lee
Journal:  Int J Hematol       Date:  2010-10-22       Impact factor: 2.490

5.  Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report.

Authors:  D Tzilves; A Gatopoulou; K Zervas; E Katodritou; F Patakiouta; A Tarpagos; I Katsos
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

6.  A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib.

Authors:  Samer Alsidawi; Abhimanyu Ghose; Julianne Qualtieri; Neetu Radhakrishnan
Journal:  Case Rep Oncol Med       Date:  2014-12-02

7.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15

8.  Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.

Authors:  Naveed Ali; Peter V Pickens; Herbert E Auerbach
Journal:  Hematol Rep       Date:  2016-03-17

9.  An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature.

Authors:  Kosuke Miki; Naoshi Obara; Kenichi Makishima; Tatsuhiro Sakamoto; Manabu Kusakabe; Takayasu Kato; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Mamiko Sakata-Yanagimoto; Yuichi Hasegawa; Shigeru Chiba
Journal:  Case Rep Hematol       Date:  2018-10-10

10.  A case of primary gastric diffuse large B-cell lymphoma occurring in chronic myeloid leukemia.

Authors:  Zhimei Cai; Shuo Liu; Jie Zi; Jinlong Ma; Zheng Ge
Journal:  Onco Targets Ther       Date:  2019-07-22       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.